M13-549
ClinicalTrials.gov NCT02675426
Research payments
$1,925,075
Through program year 2020, $1,925,075 in research payments was reported against M13-549, across 997 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT02675426
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $905,017 | 466 |
| 2019 | Research | $1,020,058 | 531 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- John Tesser Phoenix, AZ Named on 77 payments
- Areena Swarup Phoenix, AZ Named on 76 payments
- Roy Fleischmann Dallas, TX Named on 39 payments
- Eric Peters Phoenix, AZ Named on 36 payments
- Christopher Phillips Paducah, KY Named on 35 payments
- Ralph Bennett Phoenix, AZ Named on 34 payments
- Melvin Churchill Lincoln, NE Named on 31 payments
- Kwabena Ayesu Orlando, FL Named on 30 payments
- Jeffrey Alper Naples, FL Named on 30 payments
- Robert Trapp Springfield, IL Named on 29 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.